Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Phase II Pilot Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma

NCT03787303 is registered in ClinicalTrials.gov with Aultman Health Foundation as lead sponsor.

NCT NCT03787303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03787303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Phase II Pilot Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma
Lead sponsor
Aultman Health Foundation
Phase
Phase 2
Overall status
Terminated
Start date
March 1, 2019
Completion date
March 9, 2022
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer, thyroid dysfunction